Canada Pension Plan Investment Board
EVLO

Canada Pension Plan Investment Board’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Canada Pension Plan Investment Board’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,250
Closed -$268K – 1417
2021
Q1 		$268K Buy
+1,250
New +$345K ﹤0.01% 1131
2020
Q4 		– Sell
-1,500
Closed -$158K – 1488
2020
Q3 		$158K Buy
+1,500
New +$137K ﹤0.01% 941

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board's EVLO Position: Q2 2021 in Review

Canada Pension Plan Investment Board sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2021, closing a stake of 1,250 shares — an estimated $268K sold.

Canada Pension Plan Investment Board first reported a position in EVLO in Q3 2020 and held it in 2 quarters. The position peaked at $268K in Q1 2021. 66 funds tracked by Wall St. Rank hold EVLO as of Q2 2021.

  • Canada Pension Plan Investment Board reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 1,250 Evelo Biosciences, Inc. Common Stock shares in Q2 2021, an estimated $268K.
  • Canada Pension Plan Investment Board first reported a position in Evelo Biosciences, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Canada Pension Plan Investment Board's Evelo Biosciences, Inc. Common Stock position peaked at $268K in Q1 2021.
  • 66 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2021.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2021, filed 16 Aug 2021.